{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:28:29Z","timestamp":1790681309105,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T00:00:00Z","timestamp":1516060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012947","name":"Institut de Recherche pour le D\u00c3\u00a9veloppement","doi-asserted-by":"publisher","award":["821849H"],"award-info":[{"award-number":["821849H"]}],"id":[{"id":"10.13039\/100012947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ijpddr.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T11:46:52Z","timestamp":1517399212000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity"],"prefix":"10.1016","volume":"8","author":[{"given":"C.","family":"Loeuillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Touquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Oury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Eddaikra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.F.","family":"Guichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Labesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.peptides.2008.05.008","article-title":"Isolation, characterization and molecular cloning of new temporins from the skin of the North African ranid Pelophylax saharica","volume":"29","author":"Abbassi","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: molecular targets and diagnosis","volume":"57","author":"Akhoundi","year":"2017","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"1","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.20082826","article-title":"Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites","volume":"2016","author":"Bougdour","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1442-9071.2012.02838.x","article-title":"Ocular toxoplasmosis II: clinical features, pathology and management","volume":"41","author":"Butler","year":"2013","journal-title":"Clin. Experiment. Ophthalmol. Times"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib6","first-page":"23","article-title":"Comparative effects of histone deacetylases inhibitors and resveratrol on Trypanosoma cruzi replication, differentiation, infectivity and gene expression","volume":"7","author":"Campo","year":"2016","journal-title":"Int. J. Parasitol.: Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1016\/j.bmc.2014.12.066","article-title":"Evaluation of histone deacetylase inhibitors (HDACi) as therapeutic leads for human African trypanosomiasis (HAT)","volume":"23","author":"Carrillo","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.bmcl.2017.01.046","article-title":"Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma","volume":"27","author":"Chellan","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib9","first-page":"42","article-title":"Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth","volume":"7","author":"Chua","year":"2016","journal-title":"Int. J. Parasitol.: Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1073\/pnas.93.23.13143","article-title":"Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase","volume":"93","author":"Darkin-Rattray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejmech.2017.04.013","article-title":"Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors","volume":"135","author":"De Vreese","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib11","first-page":"117","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol.: Drugs. Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib12","first-page":"257","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"Franco","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib13","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/acs.jmedchem.6b01595","article-title":"Lysine deacetylase inhibitors in parasites: past, present, and future perspectives","volume":"60","author":"Hailu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.ejmech.2009.06.010","article-title":"Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors","volume":"44","author":"Jiao","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11721-007-0006-9","article-title":"An ant colony optimization approach to flexible protein-ligand docking","volume":"1","author":"Korb","year":"2007","journal-title":"Swarm. Intell"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1128\/AAC.48.4.1435-1436.2004","article-title":"Antimalarial and antileishmanial activities of aroyl-pyrrolyl- hydroxyamides, a new class of histone deacetylase inhibitors","volume":"48","author":"Mai","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/epi.3.1.5736","article-title":"HDACs and HDAC inhibitors in colon cancer","volume":"3","author":"Mariadason","year":"2008","journal-title":"Epigenetics"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/AAC.00462-10","article-title":"Activity of the histone deacetylase inhibitor FR235222 on Toxoplasma gondii: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds","volume":"54","author":"Maubon","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(16)30171-4","article-title":"Neglected tropical diseases: progress towards addressing the chronic pandemic","volume":"389","author":"Molyneux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/AAC.02009-15","article-title":"Clinically available medicines demonstrating anti-Toxoplasma activity","volume":"59","author":"Neville","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"W485","DOI":"10.1093\/nar\/gkp368","article-title":"@TOME-2: a new pipeline for comparative modeling of protein-ligand complexes","volume":"37","author":"Pons","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/2159-8290.CD-12-0076","article-title":"Emerging epigenetic targets and therapies in cancer medicine","volume":"2","author":"Popovic","year":"2012","journal-title":"Canc. Discov."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1016\/S0040-4039(00)01058-3","article-title":"A convenient method for the preparation of hydroxamic acids","volume":"41","author":"Reddy","year":"2010","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib28","doi-asserted-by":"crossref","first-page":"10301","DOI":"10.1128\/MCB.25.23.10301-10314.2005","article-title":"Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii","volume":"25","author":"Saksouk","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib29","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1128\/AAC.02406-13","article-title":"Transmission potential of antimony-resistant leishmania field isolates","volume":"58","author":"Seblova","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib30","first-page":"200","article-title":"Antimony resistance and environment: elusive link to explore during Leishmania life-cycle","volume":"2","author":"Sereno","year":"2012","journal-title":"Int. J. Parasitol.: Drugs. Drug Resist"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib31","series-title":"New Compounds for the Treatment And\/or Prevention of Parasitic Diseases and Method of Production Thereof","author":"Sereno","year":"2014"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1128\/AAC.49.2.808-812.2005","article-title":"In vitro antileishmanial activity of nicotinamide","volume":"49","author":"Sereno","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.45.4.1168-1173.2001","article-title":"DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening","volume":"45","author":"Sereno","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib34","series-title":"Pharmaceutical Composition for the Treatment of Leishmaniasis","author":"Sereno","year":"2008"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2012.01.001","article-title":"Anti-Trypanosoma cruzi activity of nicotinamide","volume":"122","author":"Soares","year":"2012","journal-title":"Acta. Trop."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.2174\/0929867320666131119121636","article-title":"Drug development against sleeping sickness: old wine in new bottles?","volume":"21","author":"Stein","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.jmb.2014.03.007","article-title":"Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen Schistosoma mansoni","volume":"426","author":"Stolfa","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0166-6851(98)00011-5","article-title":"Expression, selection, and organellar targeting of the green fluorescent protein in Toxoplasma gondii","volume":"92","author":"Striepen","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1645\/GE-1043R.1","article-title":"Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro","volume":"93","author":"Strobl","year":"2007","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib40","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s10495-010-0521-9","article-title":"Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells","volume":"15","author":"Sung","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib41","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib42","first-page":"1","article-title":"Chemotherapy of leishmaniasis: present challenges","volume":"S1","author":"Uliana","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.actatropica.2005.03.004","article-title":"Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase","volume":"94","author":"Vergnes","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib44","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1021\/jm301355j","article-title":"Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif","volume":"56","author":"Wagner","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2018.01.002_bib45","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijpddr.2018.01.002_bib46","article-title":"Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity","author":"Zingales","year":"2017","journal-title":"Acta Trop."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717301240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:21Z","timestamp":1761922101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717301240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2211320717301240"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.01.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}